However, under the “no therapy” condition, the overall cancer survival rate in cancer patients with mutated ABCB1 (n = 711) was indeed significantly decreased when compared with unmutated ABCB1 control (n = 6,278) (Figure 7H, log-rank test, P-value = 7.93E-3). Here, ABCB1 is linked to cancer.